Constitutive expression of G-CSF and GM-CSF in human skin carcinoma cells with functional consequence for tumor progression

被引:0
|
作者
Mueller, MM [1 ]
Fusenig, NE [1 ]
机构
[1] German Canc Res Ctr, Div Carcinogenesis & Differentiat, D-69120 Heidelberg, Germany
关键词
D O I
10.1002/(SICI)1097-0215(19991210)83:6<780::AID-IJC14>3.3.CO;2-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor progression is characterized by an increasing escape of tumor cells from the growth control of their microenvironment, often caused by aberrant expression of growth factors. In the human skin carcinoma model system, based on the HaCaT keratinocyte line, tumor progression to high-grade malignant cells is associated with constitutive expression and secretion of the hematopoietic growth factors G-CSF and GM-CSF in vitro and in vivo. All HaCaT keratinocyte variants express the G-CSF and the GM-CSF receptors at levels comparable to normal keratinocytes. Consequently, they exhibit: a stimulation of cell proliferation and migration in culture when treated with these factors. Moreover, both proliferation and migration of the high-grade malignant cells were strongly inhibited by neutralizing antibodies to G-CSF and GM-CSF, respectively. This demonstrates the functional role of these factors in high-grade malignant HaCaT cells through an autocrine mechanism in vitro and implies their significance in tumor progression in vivo. In light: of the increasing use of G-CSF and GM-CSF in adjuvant tumor therapy, our data, as well as those discussed for head-and-neck tumors and gliomas, warrant a careful re-evaluation of the clinical application of both factors. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:780 / 789
页数:10
相关论文
共 50 条
  • [21] Granulocyte interactions with GM-CSF and G-CSF secretion by endothelial cells and monocytes
    Lenhoff, S
    Rosberg, B
    Olofsson, T
    EUROPEAN CYTOKINE NETWORK, 1999, 10 (04) : 525 - 532
  • [22] RESPONSE OF LEUKEMIC-CELLS TO THE SEQUENTIAL COMBINATION OF GM-CSF AND G-CSF
    INOUE, C
    MURATE, T
    HOTTA, T
    SAITO, H
    INTERNATIONAL JOURNAL OF CELL CLONING, 1990, 8 (01): : 54 - 62
  • [23] MONOKINE MODULATION OF HUMAN NEUROGLIAL CELL PRODUCTION OF G-CSF AND GM-CSF
    TWEARDY, DJ
    GLAZER, EW
    CLINICAL RESEARCH, 1988, 36 (03): : A474 - A474
  • [24] DIFFERENTIAL EFFECT OF GM-CSF AND G-CSF IN CYCLIC NEUTROPENIA
    FREUND, MRF
    LUFT, S
    SCHOBER, C
    HEUSSNER, P
    SCHREZENMAIER, H
    PORZSOLT, F
    WELTE, K
    LANCET, 1990, 336 (8710): : 313 - 313
  • [25] G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis
    Cornish, Ann L.
    Campbell, Ian K.
    McKenzie, Brent S.
    Chatfield, Simon
    Wicks, Ian P.
    NATURE REVIEWS RHEUMATOLOGY, 2009, 5 (10) : 554 - 559
  • [26] Immune Evasion of G-CSF and GM-CSF in Lung Cancer
    Park, Yeonhee
    Chung, Chaeuk
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2024, 87 (01) : 22 - 30
  • [27] The potential role of GM-CSF and G-CSF in infectious diseases
    Deresinski, SC
    Kemper, CA
    INFECTIONS IN MEDICINE, 1998, 15 (12) : 856 - +
  • [28] G-CSF AND GM-CSF - BIOLOGY AND CLINICAL-APPLICATION
    GOLDE, DW
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (03): : 319 - 319
  • [29] THE USE OF GM-CSF AND G-CSF IN THE TREATMENT OF ACUTE LEUKEMIAS
    HAROUSSEAU, JL
    WU, DP
    LEUKEMIA & LYMPHOMA, 1995, 18 (5-6) : 405 - 412
  • [30] DIFFERENCES IN THE NEUTROPHIL PRIMING EFFECTS OF G-CSF AND GM-CSF
    TREWEEKE, AT
    AZIZ, KA
    ZUZEL, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 : 66 - 66